Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Unspecified B-Cell Lymphomas.

Penn cell therapy spinout Verismo Therapeutics has a new owner. Here's how the deal came together and why everyone is telling ...

BGBC-354 is under clinical development by BeiGene and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...

Clayton Moorse's parents couldn't slip a T-shirt over his torso because of his distended stomach. Tests revealed the toddler ...

Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time.

CHF 50 Million extension round co-led by Cormorant Asset Management, with participation from other existing investorsProceeds will be used to ...

Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a $7.1 million seed ...

Denise Richards’ husband, Aaron Phypers, is being sued for alleged fraud and breach of oral contract. Rupert Perry filed a ...

There's another legal issue for Mr. Denise Richards. The post Denise Richards’ Husband Aaron Phypers Sued for Alleged Fraud ...

HONG KONG, Jan 9, 2025 - (ACN Newswire) – The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders frantically.

South San Francisco company said Monday. It is the second round of large layoffs at the company (Nasdaq: CTMX), reflecting the protracted financial downturn in the life sciences industry. CytomX cut ...

Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation ...